DIRECT COSTS OF TYPE 2 DIABETES: A BRAZILIAN COST-OF-ILLNESS STUDY.
Henriques, Ricardo Saad; Steimbach, Laiza Maria; Baptista, Deise Regina; Lenzi, Luana; Tonin, Fernanda S; Pontarolo, Roberto; Wiens, Astrid.
Int J Technol Assess Health Care
; 34(2): 180-188, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29633674
The impact of financial barriers on access to care, quality of care and vascular morbidity among patients with diabetes and coronary heart disease.
Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.
Value-Based Payments and Incentives to Improve Care: A Case Study of Patients with Type 2 Diabetes in Medicare Advantage.
Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs.
HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
Early discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysis.
Increase in the pharmacological management of Type 2 diabetes with pay-for-performance in primary care in the UK.
Hemoglobin A1c improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: a nested cohort study.
HeLP-Diabetes: randomised controlled trial protocol.
Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes.